Switching from Wegovy Injection to Wegovy Tablet UK: What to Know

# Switching from Wegovy Injection to Wegovy Tablet UK: What to Know

The Wegovy tablet — oral semaglutide — was approved by the MHRA on 11 June 2026, and one of the first groups of people to consider it are those already on the Wegovy injection. Both products contain the same active ingredient: semaglutide. For people whose only barrier to treatment was the weekly injection, the tablet immediately looks like a better fit.

But switching is not as simple as swapping one pack for another. The two formulations work quite differently, and any change in your treatment must be guided by your prescriber. This guide explains what the differences mean in practice, why the switch requires clinical oversight, and what questions you should be asking.

> **Medical disclaimer:** Wegovy tablets and the Wegovy injection are both prescription-only medicines. Always consult a qualified healthcare professional before starting or changing treatment. **You must not self-switch between formulations** — dose conversion between injection and tablet is complex and must be assessed by a prescriber. The information in this guide is general and does not replace the advice of your clinician or the patient information leaflet supplied with your medication.

—

## Why people on the injection want to switch to the tablet

The most common reasons people on the Wegovy injection consider switching are straightforward:

**Needle phobia.** For many people, the weekly injection is something they tolerate rather than something they are comfortable with. The anticipation of the injection, the act itself, and the lingering discomfort can be a consistent source of stress. If the injection was the main drawback of an otherwise effective treatment, removing the needle entirely is a significant quality-of-life improvement.

**Travel.** Wegovy injection must be refrigerated (2–8°C) and counts as a sharp — meaning separate handling at airport security, careful packing in carry-on luggage (not hold baggage), and sharps disposal at your destination. For frequent travellers, this is a meaningful logistical burden. The Wegovy tablet needs no refrigeration, has no airport declaration requirement, and fits in any travel bag.

**Routine fit.** For some people, a daily tablet aligns better with their existing habits than a weekly injection — if you already take daily medication, adding the Wegovy tablet is a low-friction addition. Others find the opposite: once-weekly is easier to manage than once-daily. This is genuinely individual.

**Cost.** The Wegovy injection from UK private providers typically costs £149–£269 per month. The Wegovy tablet starts from £64 per month. If you are paying out of pocket, this difference is substantial over the course of a treatment programme.

—

## The key differences you must understand before switching

These are not administrative differences. They are clinically significant, and they are why any switch must be managed by a prescriber.

### The doses are not equivalent

Wegovy injection doses are 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg (weekly). Wegovy tablet doses are 1.5mg, 4mg, 9mg, and 25mg (daily). These numbers look wildly different, and they are — because the two formulations have completely different bioavailability.

**Bioavailability** is the proportion of a drug that reaches your bloodstream. The Wegovy injection has approximately 89% bioavailability — nearly all of what you inject is absorbed. The Wegovy tablet has approximately 1–2% bioavailability, because most oral semaglutide is broken down in the digestive system before it reaches the bloodstream. The much higher tablet doses are designed to compensate for this.

What this means in practice: you cannot look at your current injection dose and identify a tablet dose that is “equivalent.” A prescriber who knows your history, your current clinical state, and your treatment goals must make that assessment. There is no established direct conversion chart that patients can use.

### Frequency changes from weekly to daily

The injection is once weekly. The tablet is once daily. Missing a single dose has different implications — and a missed dose means something different depending on where you are in your treatment. Your prescriber will advise on what to do if you miss the tablet.

### The tablet requires a fasting window every morning

This is perhaps the most practically significant change for people coming from the injection. The Wegovy tablet must be taken on waking, with no more than 120ml of plain still water (no tea, no coffee, no milk), and you must wait at least 30 minutes before eating or drinking anything else. This is a fixed daily requirement, not optional.

For people who currently have coffee first thing, this requires a genuine routine adjustment. If you cannot reliably maintain this window — due to shift work, early morning childcare, or your existing daily habits — it is worth discussing honestly with your prescriber before deciding to switch.

The injection has no such fasting requirement.

### The weight loss ceiling may be slightly lower

Clinical trial data shows the Wegovy injection (STEP trials) produced approximately 20.7% average weight loss at maximum dose. The Wegovy tablet (OASIS trials) produced approximately 14–16% average weight loss at maximum dose. This difference is real, though averages mask significant individual variation.

If you have achieved substantial weight loss on the injection and are near your goal, this is worth factoring in. If you are earlier in treatment and switching primarily to remove the needle, the difference may be acceptable to you — that is a decision to make with your prescriber, with full information.

—

## The switching process: what actually happens

### You cannot self-switch. A prescriber must be involved.

This is not a procedural nicety. There is no established dose conversion that patients can apply themselves, and starting at the wrong tablet dose — either too high or too low — carries real risks. Too high risks significant gastrointestinal side effects; too low means potentially ineffective treatment after disrupting what was working.

### A new clinical assessment is required

Even if you have been on the Wegovy injection for a long time, obtaining a Wegovy tablet prescription requires a fresh clinical assessment. This assessment will typically cover: your current injection dose, how long you have been on that dose, your weight loss progress to date, any side effects, and your reasons for wanting to switch.

Your current injection provider may not supply the tablet — it is a separate product with a different supply chain, and not all providers who stock the injection have the tablet available. You may need to register with a new provider entirely. This means a new assessment even if your medical history is the same.

### Expect to restart the dose escalation schedule

Most prescribers will not start the tablet at a dose intended to match the effect of the injection dose you were on. They will typically begin with the lowest tablet dose (1.5mg) and escalate according to the standard tablet schedule. This is to allow your gastrointestinal system to adjust to the oral formulation — the delivery mechanism is completely different from the injection, and the side effect profile, while similar in type, can present differently.

This may feel like “going back to the beginning.” In terms of dose, that is essentially correct. Your body has adapted to semaglutide, which may reduce the early side effects compared to someone starting semaglutide for the first time — but the dose escalation is still necessary.

—

## Who is a good candidate for switching?

People likely to benefit from switching to the Wegovy tablet include:

– Those who have been on the injection and are progressing well, but find the needle genuinely stressful or uncomfortable
– Frequent travellers for whom injection storage and transport is a persistent logistical problem
– People who already take daily oral medication and for whom adding a daily tablet is low friction
– People for whom the lower tablet cost would make continuing treatment financially sustainable when the injection cost was a strain

### Who should think carefully before switching

– People who are close to their weight loss goal on the injection — restarting the dose escalation on the tablet means a period of lower dosing during which the tablet’s effect may be less than what you have become used to
– People who find daily fasting before morning coffee or food genuinely impractical — the fasting requirement is non-negotiable
– People who have achieved maximum weight loss on the injection and are maintaining — disrupting a working treatment without clear benefit is worth discussing carefully with your prescriber

—

## Frequently asked questions

### Can I switch to the Wegovy tablet straight away if I want to?

Not without a prescriber’s involvement. Switching from the Wegovy injection to the tablet requires a new clinical assessment and a new prescription, even if you have been on semaglutide for a long time. Your current provider may not supply the tablet, so you may also need to register with a new provider. Speak to your prescriber about switching before making any changes.

### Will I lose the weight loss progress I made on the injection?

Switching formulations does not reverse the weight you have already lost. However, restarting the dose escalation on the tablet means a period at lower doses where the appetite-suppressive effect may be less strong than you are used to on a higher injection dose. Some people find this manageable; others find appetite returns more noticeably during the transition. Your prescriber will help you understand what to expect.

### Do I need a completely new prescription for the tablet?

Yes. The Wegovy tablet and the Wegovy injection are different products. Even if you have an active injection prescription, you will need a separate prescription for the tablet, which requires a new clinical assessment. Your injection provider may or may not offer the tablet — if not, you will need to register with a provider who does.

### Is the Wegovy tablet as effective as the injection?

Clinical trials show the tablet produces approximately 14–16% average weight loss at maximum dose, compared to approximately 20.7% for the injection. This means the injection has an advantage in expected maximum weight loss for most people. Whether this difference matters to you depends on your goals, your starting point, and your reasons for considering the switch. Discuss with your prescriber.

### Will I have to start the dose escalation from scratch?

In most cases, yes — your prescriber will likely start you on the lowest tablet dose (1.5mg) and escalate according to the standard schedule. This is standard practice, not a sign that your previous treatment is being ignored. It allows your body to adjust to the oral formulation safely.

### How long will the switch process take?

From deciding to switch to having a tablet prescription in hand, most people should expect at least one to two weeks for a new online assessment to be completed and a prescription issued. This timeline varies by provider. Plan ahead rather than letting your injection supply run out first.

—

*This article is for informational purposes only and does not constitute medical advice. Wegovy tablets (oral semaglutide) are a prescription-only medicine available in the UK. Always consult a registered UK healthcare professional before starting or changing treatment, and follow the patient information leaflet supplied with your medication. You must not self-switch between injection and tablet formulations. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*